Rule 8.1- Reed Health Group

RNS Number:9834T
James Reed & Partners PLC
11 November 2005


                                   FORM 8.1
          DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
                  FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
      (Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)

1. KEY INFORMATION

Name of person dealing (Note 1)                             JAMES REED &
                                                            PARTNERS PLC

Company dealt in                                            REED HEALTH GROUP
                                                            PLC

Class of relevant security to which the dealings being      ORDINARY SHARES
disclosed relate (Note 2)

Date of dealing                                             10 NOVEMBER 2005


2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)

                                                      Long            Short
                                               Number (%)           Number (%)
(1) Relevant
securities                                     4,597,804 (14.01%)   N/A
(2) Derivatives (other than options)           N/A                  N/A
(3) Options and agreements to purchase/sell    N/A                  N/A
                                       Total

(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)

          Class of relevant security:                 Long          Short
                                                  Number (%)     Number (%)
(1) Relevant securities                           N/A            N/A
(2) Derivatives (other than options)              N/A            N/A
(3) Options and agreements to purchase/sell       N/A            N/A
                                          Total

(c) Rights to subscribe (Note 3)

Class of relevant security:                                  Details
N/A                                                          N/A


3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale     Number of securities          Price per unit (Note 5)
PURCHASE                       125,500                              55p

(b) Derivatives transactions (other than options)

Product      Long/short (Note   Number of securities (Note Price per unit (Note
name,        6)                 7)                         5)
e.g. CFD
N/A          N/A                N/A                        N/A


(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying

Product  Writing,     Number of         Exercise   Type, e.g. Expiry   Option
name,    selling,     securities to                American,           money
         purchasing,  which the option             European
         varying      relates (Note 7)             etc.
         etc.
e.g.                                    price                 date     paid/
call                                                                   received
option                                                                 per unit
                                                                       (Note 5)

N/A      N/A          N/A               N/A        N/A        N/A      N/A

(ii) Exercising

Product name, e.g. call      Number of            Exercise price per unit (Note
option                       securities           5)
N/A                          N/A                  N/A

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8) Details   Price per unit (if applicable) (Note 5)

N/A                            N/A       N/A


4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
N/A

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure                                            11 NOVEMBER 2005

Contact name                                                  STEVE DAVEY

Telephone number                                              020 7484 4046

Name of offeree/offeror with which associated                 OFFEROR
Specify category and nature of associate status (Note 10)


Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
DCCDBLFFEFBLFBB
Reed Health (LSE:RHG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024